Fructose consumption and leptin resistance: What have we learnt from animal studies?

Leptin: Hormonal Functions, Dysfunctions and Clinical Uses

Volumn , Issue , 2011, Pages 209-230

  Alegret, Marta ^a   Roglans, Núria ^a   Laguna, Juan C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867700830     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (123)

1. Hu, FB, Malik, VS: Sugar-sweetened beverages and risk of obesity ant type 2 diabetes: Epidemilogic evidence. Physiol & Behav 100:47-54, 2010
2. Malik, VS, Popkin, BM, Bray, GA, Després, J-P, Hu, FB: Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 121:1356-1364, 2010
3. Apovian, CM: Sugar-sweetened soft drinks, obesity, and type 2 diabetes. J Am Med Ass 292:978-989, 2004
4. Duffey, KJ, Popkin, BM: Shifts in patterns and consumption of beverages between 1965 and 2002. Obesity 119:2739-2747, 2007
5. Bray, GA: The battle of the bulge. Pittsburg PA, Dorrance Publishing, 2007,
6. Steyn, NP, Myburgh, NG, Nel, JH: Evidence to support a food-based dietary guideline on sugar consumption in South Africa. Bull World Health Organ 81:599-608, 2003
7. Adair, LS, Popkin, BM: Are child eating patterns being transformed globally. Obes Res 13:1281-1299, 2005
8. Chacko, E, McDuff, I, Jackson, R: Replacing sugar-based soft drinks with sugar-free alternatives could slow the progress of the obesity epidemic: have your Coke and drink it too. N Z Med J 116:U649, 2003
9. Brownell, KD, Farley, T, Willett, WC, Popkin, BM, Chaloupka, FJ, Thonsom, JW, Ludwig, DS: The public health and economic benefits of taxing sugar-sweetended beverages. N Eng J Med 361:1599-1605, 2009
10. Johnson, RJ, Appel, LJ, Brands, M, Howard, BV, Lefevre, M, Lusting, RH, Sacks, F, Steffen, LM, Wylie-Roset, J, American Heart Association Nutrition Committee on the Council on Nutrition, PAaMatCoEaP: Dietary sugar inkate and cardiovascular health: a scientifi statement from the American Heart Association. Circulation 120:1011-1020, 2009
11. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB: Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. J Am Med Assoc 292:927-934, 2004
12. Palmer JR, Boggs DA, Krishnan S, Hu FB, Singer M, Rosenberg L: Sugar-sweetened beverages and inidence of type 2 diabetes mellitus in african american women. Arch Intern Med 168:1487-1492, 2008
13. Lê K-A, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, Boesch C, Ravussin E, Tappy L: A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in helathy humans. Am J Clin Nutr 84:1374-1379, 2006
14. Stanhope, KL, Schwarz, JM, Keim, NL, Griffen, SC, Bremer, AA, Graham, JL, Hatcher, B, Cox, CL, Dyanchenko, A, Zhang, W, McGahan, JP, Seibert, A, Krauss, RM, Chiu, S, Schaefer, EJ, Ai, M, Otokozawa, S, Nakajima, K, Nakano, T, Beysen, C, Hellerstein, MK, Berglund, L, Havel, PJ: Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119:1322-1334, 2009
15. Ngo Sock, ET, Le, KA, Ith, M, Kreiss, R, Boesch, C, Tappy, L: Effects of a short-term overfeeding with fructose or glucose in healthy young males. Br J Nutr 103:939-943, 2010
16. Meyer, KA, Kushi, LH, Jacobs, DR, Slavin, J, Sellers, TA, Folsom, AR: Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71:921-930, 2000
17. Janket, S-J, Manson, JE, Sesso, H, Buring, JE, Liu, S: A prospective study of sugar intake and risk of type 2 diabetes in women. Diabetes Care 26:1008-1015, 2003
18. Montonen, J, Jarvinen, R, Knekt, P, Heliovaara, M, Reunanen, A: Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr 137:1447-1454, 2007
19. Couchepin, C, Lê, K-A, Bortolotti, M, Amarante da Encarnaçao, J, Oboni, J-B, Tran, C, Scheiter, P, Tappy, L: Markedly blunted metabolic effects of fructose in healthy young female subjects compared with male subjects. Diabetes Care 31:1254-1256, 2008
20. Dirlewanger, M, Schneiter, P, Jequier, E, Tappy, L: Effects of fructose on hepatic glucose metabolism in humans. Am J Physiol Endocrinol Metabol 279:E907-E911, 2000
21. Dhingra, R, Sullivan, L, Jacques, PF, Wang, TJ, Fox, CS, Meigs, JB, D'Agostino, RB, Michael Gaziano, J, Vasan, RS: Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 116:480-488, 2007
22. Lutsey, PL, Steffen, LM, Stevens, J: Dietary intake and the development of the metabolic syndrome. The Atherosclerosis Risk in Communities Study. Circulation 117:754-761, 2008
23. Perez-Pozo, SE, Schold, J, Nakagawa, T, Sánchez-Losada, LG, Johnson, RJ, López Lillo, J: Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Ob 34:454-461, 2010
24. Welsh, JA, Sharma, A, Abramson, JL, Vaccarino, V, Gillespie, C, Vos, MB: Caloric sweetener consumption and dyslipemia among US adults. J Am Med Ass 303:1490-1497, 2010
25. Teff, KL, Elliott, SS, Tschop, M, Kieffer, TJ, Rader, D, Heiman, M, Townsend, RR, Keim, NL, D'Alessio, D, Havel, PJ: Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 89:2963-2972, 2004
26. Faeh, D, Minehira, K, Schwarz, JM, Periasamy, R, Park, S, Tappy, L: Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes 54:1907-1913, 2005
27. Macdonald, I: Influence of fructose and glucose on serum lipid levels in men and pre-and postmenopausal women. Am J Clin Nutr 18:360-372, 2010
28. Stanhope, KL, Griffen, SC, Bair, BR, Swarbrick, MM, Keim, NL, Havel, PJ: Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose cornsyrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr 87:1194-1203, 2008
29. Swarbrick, MM, Stanhope, KL, Elliott, SS, Graham, JL, Krauss, RM, Christiansen, MP, Griffen, SC, Keim, NL, Havel, PJ: Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br J Nutr 100:947-952, 2008
30. Parks, EJ, Skokan, LE, Timlin, MT, Dingfelder, CS: Dietary sugars stimulate fatty acid synthesis in adults. J Nutr 138:1039-1046, 2008
31. Abde-Sayed, A, Binnert, C, Le, KA, Bortolotti, M, Schneiter, P, Tappy, L: A high-fructose diet impairs basal and stress-mediated lipid metabolism in healthy male subjects. Br J Nutr 100:393-399, 2008
32. Choi, HK, Curhan, G: Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. Br Med J 336:309-312, 2010
33. Bomback, AS, Derebail, VK, Shoham, DK, Anderson, CA, Steffen, LM, Rosamond, WD, Kshirsagar, AV: Sugar-sweetened soda consumption, hyperuricemia and kidney disease. Kidney Int 77:609-616, 2010
34. Sun, SZ, Flickinger, BD, Williamson-Hughes, PS, Empie, MW: Lack of association between dietary fructose and hyperuricemia risk in adults. Nutr Metabol 7:16-28, 2010
35. Zawiasa, A, Szklarek-Kubicka, M, Fijalkowska-Morawska, J, Nowak, D, Rysz, J, Mamelka, B, Nowicki, M: Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus. Transpl Proc 41:188-191, 2009
36. Chen, L, Caballero, B, Mitchell, DC, Loria, C, Lin, P-H, Champagne, CM, Elmer, PJ, Ard, JD, Batch, BC, Anderson, CAM, Appel, LJ: Reducing consumption of sugar-sweetened beverages is associated with reduced blood pressure. A prospective study among United States adults. Circulation 121:2398-2406, 2010
37. Forman, JP, Choi, H, Curhan, GC: Fructose and vitamin C intake do not influence risk for developing hypertension. J Am Ass Nephrol 20:863-871, 2009
38. Brown, CM, Dulloo, AC, Yepuri, C, Montani, J-P: Fructose ingestion acutely elevates blood pressure in healthy young humans. Am: J Physiol Regul Integr Comp Physiol 294:R730-R737, 2008
39. Ouyang, X, Cirillo, P, Sautin, Y, McCall, S, Bruchette, JL, Diehl, AM, Johnson, RJ, Abdelmalek, MF: Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48:993-999, 2008
40. Fried, SK, Rao, SP: Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 78:873S-880S, 2003
41. Elliott, SS, Keim, NL, Stern, JS, Teff, K, Havel, PJ: Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76:911-922, 2002
42. Thorens, B, Mueckler, M: Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 298:E141-E145, 2010
43. Davidson, NO, Hausman, AM, Ifkovits, CA, Buse, JB, Gould, GW, Burant, CF, Bell, GI: Human intestinal glucose transporter expression and localization of GLUT5. Am J Physiol 262:C795-C800, 1992
44. Douard, V, Ferraris, RP: Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab 295:E227-E237, 2008
45. Douard, V, Cui, XL, Soteropoulos, P, Ferraris, RP: Dexamethasone sensitizes the neonatal intestine to fructose induction of intestinal fructose transporter (Slc2A5) function. Endocrinology 149:409-423, 2008
46. Shu, R, David, ES, Ferraris, RP: Dietary fructose enhances intestinal fructose transport and GLUT5 expression in weaning rats. Am J Physiol 272:G446-G453, 1997
47. Havel, PJ: Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63:133-157, 2005
48. Perin, N, Keelan, M, Jarocka-Cyrta, E, Clandinin, MT, Thomson, AB: Ontogeny of intestinal adaptation in rats in response to isocaloric changes in dietary lipids. Am J Physiol 273:G713-G720, 1997
49. Lim, JS, Mietus-Snyder, M, Valente, A, Schwarz, JM, Lustig, RH: The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 7:251-264, 2010
50. Tappy, L, Le, KA: Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 90:23-46, 2010
51. Korieh, A, Crouzoulon, G: Dietary regulation of fructose metabolism in the intestine and in the liver of the rat. Duration of the effects of a high fructose diet after the return to the standard diet. Arch Int Physiol Biochim Biophys 99:455-460, 1991
52. Hommes, FA: Inborn errors of fructose metabolism. Am J Clin Nutr 58:788S-795S, 1993
53. Hardie, DG: Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144:5179-5183, 2003
54. Segal, MS, Gollub, E, Johnson, RJ: Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index. Eur J Nutr 46:406-417, 2007
55. Frayn, KN, Kingman, SM: Dietary sugars and lipid metabolism in humans. Am J Clin Nutr 62:250S-261S, 1995
56. Foretz, M, Guichard, C, Ferre, P, Foufelle, F: Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A 96:12737-12742, 1999
57. Iizuka, K, Horikawa, Y: ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J 55:617-624, 2008
58. Koo, HY, Miyashita, M, Cho, BH, Nakamura, MT: Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus. Biochem Biophys Res Commun 390:285-289, 2009
59. Nagai, Y, Nishio, Y, Nakamura, T, Maegawa, H, Kikkawa, R, Kashiwagi, A: Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Am J Physiol Endocrinol Metab 282:E1180-E1190, 2002
60. Roglans, N, Vila, L, Farre, M, Alegret, M, Sanchez, RM, Vazquez-Carrera, M, Laguna, JC: Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 45:778-788, 2007
61. Kabashima, T, Kawaguchi, T, Wadzinski, BE, Uyeda, K: Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A 100:5107-5112, 2003
62. Taghibiglou, C, Carpentier, A, Van Iderstine, SC, Chen, B, Rudy, D, Aiton, A, Lewis, GF, Adeli, K: Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275:8416-8425, 2000
63. Chong, T, Naples, M, Federico, L, Taylor, D, Smith, GJ, Cheung, RC, Adeli, K: Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia. Atherosclerosis 185:21-31, 2006
64. Siri, P, Candela, N, Zhang, YL, Ko, C, Eusufzai, S, Ginsberg, HN, Huang, LS: Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance. J Biol Chem 276:46064-46072, 2001
65. Hirano, T, Mamo, JC, Poapst, ME, Kuksis, A, Steiner, G: Impaired very low-density lipoprotein-triglyceride catabolism in acute and chronic fructose-fed rats. Am J Physiol 256:E559-E565, 1989
66. Anurag, P, Anuradha, CV: Metformin improves lipid metabolism and attenuates lipid peroxidation in high fructose-fed rats. Diabetes Obes Metab 4:36-42, 2002
67. Malik, VS, Schulze, MB, Hu, FB: Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr 84:274-288, 2006
68. Bezerra, RM, Ueno, M, Silva, MS, Tavares, DQ, Carvalho, CR, Saad, MJ: A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr 130:1531-1535, 2000
69. Pagliassotti, MJ, Kang, J, Thresher, JS, Sung, CK, Bizeau, ME: Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance. Am J Physiol Endocrinol Metab 282:E170-E176, 2002
70. Gum, RJ, Gaede, LL, Koterski, SL, Heindel, M, Clampit, JE, Zinker, BA, Trevillyan, JM, Ulrich, RG, Jirousek, MR, Rondinone, CM: Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 52:21-28, 2003
71. Taghibiglou, C, Rashid-Kolvear, F, Van Iderstine, SC, Le-Tien, H, Fantus, IG, Lewis, GF, Adeli, K: Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 277:793-803, 2002
72. Wei, Y, Pagliassotti, MJ: Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. Am J Physiol Endocrinol Metab 287:E926-E933, 2004
73. Hirosumi, J, Tuncman, G, Chang, L, Gorgun, CZ, Uysal, KT, Maeda, K, Karin, M, Hotamisligil, GS: A central role for JNK in obesity and insulin resistance. Nature 420:333-336, 2002
74. Wei, Y, Wang, D, Topczewski, F, Pagliassotti, MJ: Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance. J Nutr Biochem 18:1-9, 2007
75. Angulo, P: GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 25:883-889, 2007
76. Tessari P, Coracina A, Cosma A, Tiengo A: Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 19:291-302, 2009
77. Roglans N, Sanguino E, Peris C, Alegret M, Vázquez M, Adzet T, Díaz C, Hernández G, Laguna JC, Sánchez RM: Atorvastatin treatment induced peroxisome proliferator-activated receptor a expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats. J Pharmacol Exp Ther 302:232-239, 2002
78. Vilà L, Roglans N, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC: Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology 48:1506-1516, 2008
79. Poulsom, R: Morphological changes of organs after sucrose or fructose feeding. Prog Biochem Pharmacol 21:104-134, 1986
80. Abdelmalek, MF, Suzuki, A, Guy, C, Unalp-Arida, A, Colvin, R, Johnson, RJ, Diehl, AM: Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51:1961-1971, 2010
81. Furuhashi, M, Ura, N, Murakami, H, Hyakukoku, M, Yamaguchi, K, Higashiura, K, Shimamoto, K: Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle. J Endocrinol 174:321-329, 2002
82. Nagai, Y, Yonemitsu, S, Erion, DM, Iwasaki, T, Stark, R, Weismann, D, Dong, J, Zhang, D, Jurczak, MJ, Loffler, MG, Cresswell, J, Yu, XX, Murray, SF, Bhanot, S, Monia, BP, Bogan, JS, Samuel, V, Shulman, GI: The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab 9:252-264, 2009
83. Neuschwander-Tetri, BA: Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52:774-788, 2010
84. Spruss, A, Kanuri, G, Wagnerberger, S, Haub, S, Bischoff, SC, Bergheim, I: Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50:1094-1104, 2009
85. Bergheim, I, Weber, S, Vos, M, Kramer, S, Volynets, V, Kaserouni, S, McClain, CJ, Bischoff, SC: Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48:983-992, 2008
86. Ahmed, MH, Byrne, CE: Current treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab 11:188-195, 2009
87. Browning, JD: Statins and hepatic steatosis: perspectives from the Dallas Heart Study. Hepatology 44:466-471, 2006
88. Preiss, D, Sattar, N: Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clin Endocrinol 70:815-828, 2009
89. Stein, EA, Lane, M, Laskarzewski, P: Comparison of statins in hypertriglyceridemia. Am J Cardiol 81:66B-69B, 1998
90. Bakker-Arkema, RG, Davidson, MH, Goldstein, RJ, Davignon, J, Issacshon, JL, Weiss, SR, Keilson, LM, Brown, WV, Miller, VT, Shurzinske, LJ, Black, DM: Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. J Am Med Assoc 275:128-133, 1996
91. Kiyici, M, Gulten, M, Gurel, S, Giray Nak, S, Dolar, E, Savci, G, Balaban Adim, S, Yerci, O, Memik, F: Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. Can J Gastroenterol 17:713-718, 2003
92. Gómez-Domínguez, E, Gisbert, JP, Moreno-Monteagudo, JA, García-Buey, L, Moreno-Otero, R: A pilot study of atorvastatin treatment in dyslipemic, non-alcoholic fatty liver patients. Aliment Pharmacol Ther 23:1643-1647, 2006
93. Rodríguez-Calvo R, Barroso E, Serrano L, Coll T, Sánchez RM, Merlos M, Palomer X, Laguna JC, Vázquez-Carrera M: Atorvstatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A. Hepatology 49:106-115, 2009
94. Park, J, Lemieux, S, Lewis, GF, Kuksis, A, Steiner, G: Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats. J Lipid Res 38:2529-2536, 1997
95. Vilà, L, Rebollo, A, Adalsteisson, GS, Alegret, M, Merlos, M, Roglans, N, Laguna, JC: Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after Atorvastatin treatment. Toxicol Appl Pharmacol 2010, in press.
96. Reiser, S: Effect of dietary sugars on metabolic risk factors associated with heart disease. Nutr Health 3:203-216, 1985
97. Woods, SC, Chavez, M, Park, CR, Riedy, C, Kaiyala, K, Richardson, RD, Figlewicz, DP, Schwartz, MW, Porte, D, Jr., Seeley, RJ: The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neurosci Biobehav Rev 20:139-144, 1996
98. Schwartz, MW, Woods, SC, Porte, D, Jr., Seeley, RJ, Baskin, DG: Central nervous system control of food intake. Nature 404:661-671, 2000
99. Caro, JF, Sinha, MK, Kolaczynski, JW, Zhang, PL, Considine, RV: Leptin: the tale of an obesity gene. Diabetes 45:1455-1462, 1996
100. Niswender, KD, Morton, GJ, Stearns, WH, Rhodes, CJ, Myers, MG, Jr., Schwartz, MW: Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413:794-795, 2001
101. Tschop, M, Weyer, C, Tataranni, PA, Devanarayan, V, Ravussin, E, Heiman, ML: Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709, 2001
102. Betz, AL, Csejtey, J, Goldstein, GW: Hexose transport and phosphorylation by capillaries isolated from rat brain. Am J Physiol 236:C96-102, 1979
103. Martinez, FJ, Rizza, RA, Romero, JC: High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension 23:456-463, 1994
104. Verma, S, Bhanot, S, McNeill, JH: Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. J Pharmacol Exp Ther 271:1334-1337, 1994
105. Dai, S, McNeill, JH: Fructose-induced hypertension in rats is concentration-and duration-dependent. J Pharmacol Toxicol Methods 33:101-107, 1995
106. Giacchetti, G, Sechi, LA, Griffin, CA, Don, BR, Mantero, F, Schambelan, M: The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue. J Hypertens 18:695-702, 2000
107. Vasdev, S, Longerich, L, Gill, V: Prevention of fructose-induced hypertension by dietary vitamins. Clin Biochem 37:1-9, 2004
108. Mayes, PA: Intermediary metabolism of fructose. Am J Clin Nutr 58:754S-765S, 1993
109. Nagata, R, Nishio, Y, Sekine, O, Nagai, Y, Maeno, Y, Ugi, S, Maegawa, H, and Kashiwagi, A: Single nucleotide polymorphism (-468 Gly to Ala) at the promoter region of sterol regulatory element-binding protein-1c associates with genetic defect of fructose-induced hepatic lipogenesis. J Biol Chem 279(28), 29031-29042. 2004.
110. Delbosc, S, Paizanis, E, Magous, R, Araiz, C, Dimo, T, Cristol, J-P, Cros, G, and Azay, J: Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 179, 43-49. 2005.
111. Wiggins, D, Hems, R, and Gibbons, GF: Decreased sensitivity in the inhibitory effect of insulin on the secretion of very-low-density lipoprotein in cultures hepatocytes from fructose-fed rats. Metabolism 44(7), 841-847. 1995.
112. Hellerstein, MK: Carbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk. Cur Opin Lipidol 13:33-40, 2002
113. Lewis, GF, Carpentier, A, Adeli, K, and Giacca, A: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine Rev 23(2), 201-229. 2002.
114. Dentin, R, Girard, J, Postic, C: Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 87:81-86, 2005
115. Lee, Y, Yu, X, Gonzales, F, Mangelsdorf, DJ, Wang, MY, Richardson, C, Witters, LA, Unger, RH: PPAR? is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc Natl Acad Sci USA 99:11848-11853, 2002
116. Münzberg, H, Björnholm, M, Bates, SH, Myers Jr, MG: Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 62:642-652, 2005
117. Bates, SH, Stearns, WH, Dundon, TA, Schubert, M, Tso, AWK, Wang, Y, Banks, AS, Lavery, HJ, Haq, AK, Maratos-Filer, E, Neel, BG, Schwartz, MW, Myers, MG Jr: STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421:856-859, 2003
118. Weng, Z, Zhong, Z, Darnell Jr, JE: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250, 1995
119. Howard, JK, Flier, JS: Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metabol 17:365-371, 2006
120. Uyeda, K, Yamashita, H, Kawaguchi, T: Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage. Biochem Pharmacol 63:2075-2080, 2002
121. Uyeda, K, Repa, JJ: Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metabol 4:107-110, 2006
122. Vila, L, Roglans, N, Pereira, V, Sánchez, RM, Vazquez-Carrera, M, Alegret, M, Laguna, JC: Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. J Nutr Biochem 2010, in press.
123. Taguchi, A, White, MF: Insulin-Like Signaling, Nutrient Homeostasis, and Life Span. Annu Rev Physiol 70:191-212, 2008